A one-size-fits-all approach to case management and patient care can be detrimental to patients and the case management profession, but so too can designing a new approach to care plans for every patient who walks through the door, according to an article in CMSA Today.
The Centers for Disease Control and Prevention (CDC), one of the Cooperating Parties responsible for the ICD-10-CM codes and guidelines, recently released a 2018 ICD-10-CM Official Guidelines for Coding and Reporting errata. Slight changes were made to the guidelines for diabetes, hypertension, and principal diagnosis selection.
Five senators recently asked the Government Accountability Office (GAO) to examine the costs and risks associated with mismatched patient records during the agency’s review of patient matching. The GAO is required by the 21st Century Cures Act to conduct an assessment on patient matching to protect patient privacy and security.
Q: We are using a biosimilar for infliximab but it is manufactured by Merck/Samsung rather than Pfizer/Hospira. CMS requires that a manufacturer specific modifier be appended to the HCPCS code. Is there a new one for Merck/Samsung?
